Cantitate/Preț
Produs

Hyperbilirubinemia as a predictor of appendiceal perforation in patients with

Autor Alexander Vicente
en Limba Engleză Paperback – 12 dec 2022
Perforated appendicitis (AP) presents a late intervention of 5 and 30%, originating an increase in mortality of 0.3% in acute appendicitis and 6.5% in the case of AP, an adequate surgical approach would decrease mortality, intrahospital stay secondary to peritonitis, sepsis of abdominal origin, abscesses, etc. For this reason, it is important to emphasize a better prognosis. Currently, studies have reported that hyperbilirubinemia produced by hepatocellular damage and intrahepatic cholestasis as a result of a decrease in portal blood flow is a predictive factor for PA. The aim of the present study was to determine serum total bilirubin levels in relation to surgical and histopathological findings, to characterize postoperative and preoperative cases, to determine whether hyperbilirubinemia is a predictor of appendiceal perforation, and to evaluate its sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). Therefore, we present this retrospective study of 107 cases attended in emergency, who have total bilirubin values as part of their preoperative assessment, and who underwent appendiceal perforation.
Citește tot Restrânge

Preț: 24705 lei

Preț vechi: 26005 lei
-5% Nou

Puncte Express: 371

Preț estimativ în valută:
4729 4928$ 3936£

Carte tipărită la comandă

Livrare economică 03-09 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9786205343654
ISBN-10: 6205343657
Pagini: 52
Dimensiuni: 150 x 220 x 4 mm
Greutate: 0.1 kg
Editura: Our Knowledge Publishing

Notă biografică

Possui graduação em Medicina pela Universidade Nacional de Loja - Equador (2016), Certificado para o exercício profissional pelo conselho de avaliação de avaliação de acreditação e garantia do ensino superior - Equador (2017). Allgemeine Chirurgie an der Päpstlichen Katholischen Universität von Rio de Janeiro - Brasilien (2022).